Presentations and Publications
2021 CommNETs Publication
Click here for: Elston, M.S., Love, A., Kevat, D., Carroll, R., Siow, Z.R., Pattison, S., Boyle, V., Segelov, E., Strickland, A.H., Wyld, D., Gauci, R., Kennedy, K., Ransom, D. CommNETs. Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours. Cancer Medicine. 2021;00:1-7. DOI: 10.1002/cam4.4345
Click here for: Koea, J., Pasieka, J. Surgical Management of Small Bowel Neuroendocrine Tumour Symposia. World J Surg 45, 195–196 (2021).
Click here for : Hallet, J., Law, C. & The Commonwealth Neuroendocrine Tumours Research Collaborative (CommNETs) Surgical Section. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors. World J Surg 45, 197–202 (2021).
Click here for: Rajaretnam, N.S., Meyer-Rochow, G.Y., The Commonwealth Neuroendocrine Tumor Research Collaborative (CommNETs) Surgical Section. et al. Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation. World J Surg 45, 203–207 (2021).
Click here for: Pasieka, J.L. Multifocal Small Bowel Neuroendocrine Tumours. World J Surg 45, 208–212 (2021).
Click here for : Hallet, J., Law, C., the Commonwealth Neuroendocrine Tumours Research Collaborative (CommNETs) Surgical Section. et al. Role of Primary Tumor Resection for Metastatic Small Bowel Neuroendocrine Tumors. World J Surg 45, 213–218 (2021).
Click here for: Koea, J., the Commonwealth Neuroendocrine Tumour Research Collaborative (CommNETs) Surgical Section., Hallett, J. et al. Management of Locally Advanced and Unresectable Small Bowel Neuroendocrine Tumours. World J Surg 45, 219–224 (2021).
2020 CommNETs Publications
Click here for: Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl L, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosburg J, Sung A, Thawer A, Wei B, Xu B, Segelov E. CommNETs and NANETS Guidelines for the Diagnosis and Management of Patients with Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 ENETS Expert Consensus Guidelines. (2020). Journal of Thoracic Oncology, 15(10), DOI: 10.1016/j.jtho.2020.06.021
Click here for: Choi, J., Koea, J.B. (2020). Why are there so few surgical trials in neuroendocrine tumours? ANZ Journal of Surgery. doi: 10.1111/ans.15798
Click here for: Gordon, L.G., Elliott, T.M., Wakelin, K., Leyden, S., Leyden, J., Michael, M., Pavlakis, P., Mumford, J., Segelov E., Wyld, D.K. (2020). The Economic Impact on Australian Patients with Neuroendocrine Tumours. The Patient – Patient-Centered Outcomes Research
2019 CommNETs Publications
Click here for: Woodhouse B., Pattison S., Segelov E., Singh S., Parker K., Kong G., Macdonald W., Wyld D., Meyer-Rochow G., Pavlakis N., Conroy S., Gordon V., Koea J., Kramer N., Michael M., Wakelin K., Asif T., Lo D., Price T., Lawrence B. (2019). Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care. Journal of Clinical Medicine, 8(9), 1455.
Click here for: Aramoana J., Koea J. (2019). An Integrative Review of the Barriers to Indigenous Peoples Participation in Biobanking and Genomic Research. J of Global Oncology 2018; Published online 7 March 2019. DOI: 10.1200/JGO.18.00156
2018 CommNETs Publications
Click here for: Chan D.L., Moody L., Segelov E., Metz D., Strosberg J., Pavlakis N., Singh S. (2018). “Follow-up for resected gastroenteropancreatic neuroendocrine tumours (GEP-NETs): A practice survey of the Commonwealth Neuroendocrine collaboration (CommNETs) and the North American Neuroendocrine Tumor Society (NANETS).” Neuroendocrinology (accepted for publication), doi:10.1159/000488394.
Click here for: Singh S., Moody L., Chan D.L. Metz D., Strosberg J., Asmis T., Bailey D., Bergsland E., Brendtro K., Carroll R., Cleary S., Kim M., Kong G., Law C., Lawrence B., McEwan S., McGregor C., Michael M., Pasieka J., Pavlakis N., Pommier R., Soulen M., Wyld D., Segelov E. (2018) “Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumours.” JAMA Oncology, doi: doi:10.1001/jamaoncol.2018.2428.
Click here for: Singh S, Chan DL, Moody L, Liu N, Fischer HD, Austin PC, Segelov E. 2018. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncology. 4:583-585. Impact factor 16.
2017 CommNETs Publications
Click here for: Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., et al. (2017). Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration., 3(4), 380–388.
CommNETs Members’ NET Publications
Click here for: Segelov, E. (2020). Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms [Special issue]. Journal of Clinical Medicine.
Click here for: Wyld, D., Wan, M.H., Moore, J., Dunn, N., Youl, P. (2019). Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, Volume 63.
To view past CommNETs Members Publications please click here
2022 Presentations
ENETS Annual Conference, March 10th-11th, Barcelona Spain
Click here for : PRRT and Quality of Life: An International Multi-Centre Study
2020 Presentations
ENETS 2020 VIRTUAL CONFERENCE
Click here for: Economic Impact Australian NETs_ENETS 2020 The economic impact to Australian patients with neuroendocrine tumours’.
Click here for the Resulting Publication Link
Click here for: Shared Care Model_ENETS 2020 Insights into the Practice Patterns, Challenges and the Role of a Shared Care Model in the Management of NET Patients in the Community.
2019 Presentations
NANETS ANNUAL MULTIDISCIPLINARY NET MEDICAL SYMPOSIUM, OCTOBER 3rd – 5th 2019, BOSTON MA
Click here for: Understanding the Treatment Preferences of NET Patients Using Discrete Choice Experiments.
Click here for the Resulting Publication Link
2018 Presentations
ANNUAL APNETS MEETING, NOVEMBER 9th – 11th 2018, MELBOURNE, VIC, AUSTRALIA
Click here for: Neuroendocrine neoplasms in the paediatric adolescent and young adult population in New Zealand and Queensland Australia.
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER WORLD CONFERENCE ON LUNG CANCER, SEPTEMBER 23RD -26TH TORONTO, ON, CAN
Click here for: Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus.
NANETs SYMPOSIUM, OCTOBER 4TH-6TH SEATTLE, WA, USA
Click here for: Ontario oncologists’ perspective on addressing potential barriers in the management of patients with neuroendocrine tumors.
Click here for: Practice Patterns, Challenges and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients.
ESMO 2018 CONGRESS OCTOBER 19TH – 23RD 2018, MUNICH GERMANY
Click here for: The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET).
Click here for the Resulting Publication Link
VCCC Survivorship Conference February 8th – 9th | Melbourne, VIC, Australia
Poster Presented by Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) PRRT Working Group.
The challenges of designing and implementing a structured, international multicentre audit on quality of life (QOL) and markers of response in patients with neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT). Poster presented: Click here